Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Locksley Qualifies for Trading on U.S. OTCQX Market October 13, 2025 Successful Completion-Impurity Removal Neutralization Tests October 13, 2025 Locksley Resources LimitedQualifies for Trading on U.S. OTCQX Market October 13, 2025